Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1978 1
1981 1
1982 1
1984 1
1985 1
1988 1
1989 2
1990 3
1991 2
1992 2
1993 2
1994 6
1995 3
1996 3
1997 11
1998 5
1999 10
2000 12
2001 10
2002 12
2003 13
2004 27
2005 18
2006 31
2007 26
2008 35
2009 39
2010 37
2011 36
2012 43
2013 52
2014 63
2015 62
2016 59
2017 46
2018 53
2019 46
2020 61
2021 67
2022 54
2023 49
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

867 results

Results by year

Filters applied: . Clear all
Page 1
Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
Geng B, Dilley M, Anterasian C. Geng B, et al. Curr Allergy Asthma Rep. 2021 Jun 10;21(6):36. doi: 10.1007/s11882-021-01013-y. Curr Allergy Asthma Rep. 2021. PMID: 34110505 Review.
RECENT FINDINGS: Biologics that target the IL-4 receptor (dupilumab), IgE (omalizumab), and IL-5 (mepolizumab, reslizumab, and benralizumab) in patients with CRSwNP have shown improvement of various metrics including Sino-Nasal Outcome Test (SNOT-22) scores, Nasal Polyp …
RECENT FINDINGS: Biologics that target the IL-4 receptor (dupilumab), IgE (omalizumab), and IL-5 (mepolizumab, reslizumab, and benralizumab) …
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.
Bachert C, Han JK, Desrosiers MY, Gevaert P, Heffler E, Hopkins C, Tversky JR, Barker P, Cohen D, Emson C, Martin UJ, Shih VH, Necander S, Kreindler JL, Jison M, Werkström V. Bachert C, et al. J Allergy Clin Immunol. 2022 Apr;149(4):1309-1317.e12. doi: 10.1016/j.jaci.2021.08.030. Epub 2021 Sep 29. J Allergy Clin Immunol. 2022. PMID: 34599979 Clinical Trial.
Coprimary end points were change from baseline to week 40 in NP score (NPS) and patient-reported mean nasal blockage score reported once every 2 weeks. RESULTS: The study population comprised 413 randomized patients (207 in the benralizumab group and 206 in the plac …
Coprimary end points were change from baseline to week 40 in NP score (NPS) and patient-reported mean nasal blockage score rep …
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis.
Oykhman P, Paramo FA, Bousquet J, Kennedy DW, Brignardello-Petersen R, Chu DK. Oykhman P, et al. J Allergy Clin Immunol. 2022 Apr;149(4):1286-1295. doi: 10.1016/j.jaci.2021.09.009. Epub 2021 Sep 17. J Allergy Clin Immunol. 2022. PMID: 34543652 Free article.
BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is an inflammatory condition of the upper airways. ...We conducted network meta-analysis of sinusitis symptoms, heath-related quality of life, rescue oral corticosteroids and surgery, endoscopic and ra …
BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is an inflammatory condition of the upper airways. ...We cond …
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
SNOT-22 was summarised for the subgroup of patients with physician-diagnosed nasal polyposis with informed consent. This study is registered with ClinicalTrials.gov, NCT03170271. ...INTERPRETATION: Our results extend the efficacy profile of benralizumab for patients …
SNOT-22 was summarised for the subgroup of patients with physician-diagnosed nasal polyposis with informed consent. This study …
Psychometric validity of the 22-item Sinonasal Outcome Test.
Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Hopkins C, et al. Clin Otolaryngol. 2009 Oct;34(5):447-54. doi: 10.1111/j.1749-4486.2009.01995.x. Clin Otolaryngol. 2009. PMID: 19793277
DESIGN, SETTING AND PARTICIPANTS: The National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis was a prospective cohort study collecting data on 3128 adult patients undergoing sinonasal surgery in 87 NHS hospitals in England and Wales. .. …
DESIGN, SETTING AND PARTICIPANTS: The National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis was …
A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis.
Miglani A, Soler ZM, Smith TL, Mace JC, Schlosser RJ. Miglani A, et al. Int Forum Allergy Rhinol. 2023 Feb;13(2):116-128. doi: 10.1002/alr.23059. Epub 2022 Sep 4. Int Forum Allergy Rhinol. 2023. PMID: 35980852 Free PMC article.
BACKGROUND: Comparative effectiveness research between endoscopic sinus surgery (ESS) and biologic therapy for severe chronic rhinosinusitis with nasal polyposis (CRSwNP) is a nascent field as new therapeutic modalities become clinically available. ...There were no …
BACKGROUND: Comparative effectiveness research between endoscopic sinus surgery (ESS) and biologic therapy for severe chronic rhinosinusitis …
Nasal Polyposis and Its Association with Cardiac Functions.
Dhiman S, Dhiman A, Azad RK, Negi PC, Lal B, Thakur JS. Dhiman S, et al. Med Princ Pract. 2021;30(6):522-526. doi: 10.1159/000517976. Epub 2021 Jun 23. Med Princ Pract. 2021. PMID: 34348323 Free PMC article. Clinical Trial.
OBJECTIVE: The aim of the study was to ascertain the effect of nasal polyposis on cardiac functions. MATERIAL AND METHODS: A prospective randomized interventional open-label endpoint-controlled study was conducted in an academic tertiary care hospital. Thirty-one pa …
OBJECTIVE: The aim of the study was to ascertain the effect of nasal polyposis on cardiac functions. MATERIAL AND METHODS: A p …
Biologics and biomarkers for asthma, urticaria, and nasal polyposis.
Casale TB. Casale TB. J Allergy Clin Immunol. 2017 May;139(5):1411-1421. doi: 10.1016/j.jaci.2017.03.006. J Allergy Clin Immunol. 2017. PMID: 28477720 Review.
The utility of biologic agents for the management of allergic diseases has been facilitated by recent advances in better characterizing patients, including identification of relevant biomarkers that predict clinical responsiveness. This has led to the ability to phenotype …
The utility of biologic agents for the management of allergic diseases has been facilitated by recent advances in better characterizing pati …
UNILATERAL VS. DIFFUSE CHRONIC RHINOSINUSITIS.
Vrljičak A, Penezić A, Gregurić T, Grgić MV, Baudoin T, Kalogjera L. Vrljičak A, et al. Acta Clin Croat. 2022 Oct;61(Suppl 4):63-69. doi: 10.20471/acc.2022.61.s4.8. Acta Clin Croat. 2022. PMID: 37250669 Free PMC article.
This study involved 150 patients who, according to EPOS guidelines, met the diagnosis of CRS without nasal polyposis. Each patient underwent a computerized tomography (CT) scan of the paranasal sinuses, which was evaluated according to the Lund-Mackay scoring …
This study involved 150 patients who, according to EPOS guidelines, met the diagnosis of CRS without nasal polyposis. Each pat …
IL-13-associated epithelial remodeling correlates with clinical severity in nasal polyposis.
Kotas ME, Patel NN, Cope EK, Gurrola JG 2nd, Goldberg AN, Pletcher SD, Seibold MA, Moore CM, Gordon ED. Kotas ME, et al. J Allergy Clin Immunol. 2023 May;151(5):1277-1285. doi: 10.1016/j.jaci.2022.12.826. Epub 2023 Feb 2. J Allergy Clin Immunol. 2023. PMID: 36736797 Free PMC article.
In contrast, CRS without polyps showed an IL-17 activation signature. IL-13 activation scores were associated with increased tuft cell, goblet cell, and mast cell scores and decreased ciliated cell scores. Furthermore, the IL-13 score was strongly asso …
In contrast, CRS without polyps showed an IL-17 activation signature. IL-13 activation scores were associated with increased tuft cel …
867 results